Commonwealth Equity Services’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,463
| Closed | -$179K | – | 4153 |
|
|
2024
Q2 | $179K | Buy |
+10,463
| New | +$179K | ﹤0.01% | 3672 |
|
|
2023
Q3 | – | Sell |
-8,401
| Closed | -$349K | – | 3906 |
|
|
2023
Q2 | $349K | Buy |
8,401
+866
| +11% | +$36K | ﹤0.01% | 2914 |
|
|
2023
Q1 | $453 | Sell |
7,535
-210
| -3% | -$13 | ﹤0.01% | 2644 |
|
|
2022
Q4 | $568K | Buy |
7,745
+799
| +12% | +$58.6K | ﹤0.01% | 2365 |
|
|
2022
Q3 | $527K | Sell |
6,946
-728
| -9% | -$55.2K | ﹤0.01% | 2362 |
|
|
2022
Q2 | $533K | Sell |
7,674
-664
| -8% | -$46.1K | ﹤0.01% | 2356 |
|
|
2022
Q1 | $690K | Sell |
8,338
-229
| -3% | -$19K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $643K | Buy |
8,567
+2,985
| +53% | +$224K | ﹤0.01% | 2321 |
|
|
2021
Q3 | $648K | Sell |
5,582
-159
| -3% | -$18.5K | ﹤0.01% | 2275 |
|
|
2021
Q2 | $1.27M | Buy |
5,741
+362
| +7% | +$80.3K | ﹤0.01% | 1744 |
|
|
2021
Q1 | $711K | Sell |
5,379
-2,121
| -28% | -$280K | ﹤0.01% | 2061 |
|
|
2020
Q4 | $1.3M | Buy |
7,500
+269
| +4% | +$46.5K | ﹤0.01% | 1490 |
|
|
2020
Q3 | $804K | Sell |
7,231
-54
| -0.7% | -$6K | ﹤0.01% | 1628 |
|
|
2020
Q2 | $432K | Buy |
7,285
+2,644
| +57% | +$157K | ﹤0.01% | 1994 |
|
|
2020
Q1 | $312K | Sell |
4,641
-295
| -6% | -$19.8K | ﹤0.01% | 2035 |
|
|
2019
Q4 | $415K | Buy |
4,936
+1,674
| +51% | +$141K | ﹤0.01% | 2057 |
|
|
2019
Q3 | $243K | Buy |
+3,262
| New | +$243K | ﹤0.01% | 2419 |
|
|
2016
Q1 | – | Sell |
-36,090
| Closed | -$807K | – | 2246 |
|
|
2015
Q4 | $807K | Buy |
+36,090
| New | +$807K | 0.01% | 1035 |
|